NCT04335279
- Conditions
- Anxiety Disorders, Behavior, COVID-19, +21 more
- Locations
-
- Sir Mortimer B. Davis Jewish General Hospital Montreal, Quebec, Canada
Clinical trial condition
Explore clinical trials studying Scleroderma. Study availability and eligibility vary by location and protocol.
NCT04335279
NCT00540566
NCT05080738
NCT00074568
NCT04588714
NCT02887495
NCT04273386
NCT03419208
NCT01959815
NCT01862926